Cognate BioServices Revenue and Competitors
Estimated Revenue & Valuation
- Cognate BioServices's estimated annual revenue is currently $19.5M per year.
- Cognate BioServices received $Undisclosed in venture funding in February 2018.
- Cognate BioServices's estimated revenue per employee is $155,000
- Cognate BioServices's total funding is $7M.
Employee Data
- Cognate BioServices has 126 Employees.
- Cognate BioServices grew their employee count by -18% last year.
Cognate BioServices's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP, Information Systems | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | VP – Global Head Quality | Reveal Email/Phone |
5 | VP, Global Head Quality | Reveal Email/Phone |
6 | Independent Director | Reveal Email/Phone |
7 | Facilities System Administrator/Radiation Safety Officer | Reveal Email/Phone |
8 | Director, Purchasing | Reveal Email/Phone |
9 | Chief Legal Officer | Reveal Email/Phone |
10 | Director Facilities | Reveal Email/Phone |
Cognate BioServices Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is Cognate BioServices?
Cognate Bioservices is a fully-integrated contract bioservices organization providing the highest level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development of cell-based products. The combination of highly experienced staff, cGMP facilities and international track record makes Cognate one of the most experienced contract manufacturers of cell based products in the world today.
keywords:N/A$7M
Total Funding
126
Number of Employees
$19.5M
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cognate BioServices News
MEMPHIS, Tenn., Jan. 27, 2021 /PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready global CDMO in the Cell and Gene Therapy industry, and Nucleus Biologics, LLC, The Cell Performance Company™, announced today a partnership for custom and commercial medias and delivery system ...
MEMPHIS, Tenn., Jan. 14, 2021 /PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready, global CDMO in the Cell and Gene Therapy industry, announced today its plans to expand cell and gene therapy manufacturing capacity, laboratory space, warehousing capabilities, and increase o ...
MEMPHIS, Aug. 20, 2020 /PRNewswire/ -- Cognate BioServices, Inc. announced today the appointments of Timothy Moore and Steven Kasok as independent non-executive members of its Board of Directors. "We are excited to welcome Tim Moore and Steve Kasok to our Board of Directors. They bring decade ...
EW Healthcare Partners has invested in Cognate BioServices. Financial terms weren't announced. Cognate BioServices is a contract ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $37.4M | 129 | 8% | N/A |
#2 | $35.1M | 130 | 31% | $11.8M |
#3 | $31.6M | 130 | 17% | N/A |
#4 | N/A | 130 | 18% | N/A |
#5 | $23.8M | 132 | 6% | N/A |
Cognate BioServices Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2018-02-21 | $Undisclosed | Undisclosed | Tennenbaum Capital Partners, LLC | Article |